SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Benny Leonard Synthetic CCD

PatientBenny Leonard
Date of birth1976-04-07
IdentifiersMRN HR-BX008-SYN; SSN (made up) 000-08-4106
Document date2026-11-01
AuthorMiriam Okafor-Rosenthal, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care at 50 after a referee's license examination found high blood pressure: exertional breathlessness and chest tightness while refereeing, an ECG showing left ventricular hypertrophy, cardiovascular risk, money worries and mood, and a cardiology consultation. Concerns: Breathless and tight in the chest late in long nights in the ring, and told his blood pressure is high; He needs his refereeing work and is afraid of losing his license; Worry about money since losing his savings years ago, and about the cost of medicines. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morningOne tablet each morningOral route2026-05-12 to 2026-06-30completedS
Losartan 100 mg with hydrochlorothiazide 25 mg, one tablet each morningOne tablet each morning; held from the sick visit; stopped at the preventive visitOral route2026-06-30 to 2026-07-28stoppedS
Atorvastatin 40 mg tablet, one each eveningOne tablet each eveningOral route2026-05-26activeS
Losartan 100 mg tablet, one each morningOne tablet each morning; hold on sick daysOral route2026-07-28activeS
Amlodipine 5 mg tablet, one each morningOne tablet each morningOral route2026-07-28activeS

Procedures

ProcedureDatesStatusEvidence
Resting 12-lead ECG: sinus rhythm at 78 per minute; left ventricular hypertrophy by voltage (Sokolow-Lyon 38 mm, Cornell 24 mm) with mild lateral T-wave flattening; PR 160 ms; QRS 96 ms; QTc 418 ms; no Q waves, pre-excitation, conduction block or Brugada pattern2026-05-12 to 2026-05-12completedS
Transthoracic echocardiogram: concentric left ventricular hypertrophy (septum 13 mm, posterior wall 12 mm, septal-to-posterior ratio 1.1, mass index 118 g/m2); ejection fraction 62% without regional wall motion abnormality; grade 1 diastolic dysfunction; left atrial volume index 36 mL/m2; no systolic anterior motion of the mitral valve or outflow tract obstruction at rest or with Valsalva; normal valves; aortic root 34 mm2026-05-26 to 2026-05-26completedS
Exercise stress echocardiogram (Bruce protocol): 9 minutes 30 seconds, about 10.5 METs; peak heart rate 156 per minute (92% of predicted); blood pressure 150/92 at rest rising to 226/98 mmHg at peak, an exaggerated response; mild breathlessness at peak without chest discomfort; no ST-segment change; no arrhythmia; normal augmentation of all wall segments, with no inducible ischemia2026-05-26 to 2026-05-26completedS
Noncontrast CT of the heart for coronary calcium: Agatston score 186 (left anterior descending 118, right coronary 52, circumflex 16), about the 80th percentile for his age and sex; no other cardiac finding2026-05-26 to 2026-05-26completedS
Resting 12-lead ECG at the sick visit: sinus tachycardia at 104 per minute; left ventricular hypertrophy by voltage, unchanged; QTc 432 ms; no ischemic change or arrhythmia2026-07-21 to 2026-07-21completedS
Advance care planning conversation, about 15 minutes, with his consent2026-07-28 to 2026-07-28completedS

Immunizations

DateVaccineStatusEvidence
2026-07-28Pneumococcal conjugate vaccine PCV20, single dose, recommended for all adults 50 and oldercompletedS
2026-07-28Recombinant zoster vaccine, dose 1 of 2completedS
2026-08-25Hepatitis B vaccine (HepB-CpG), dose 1 of 2, after a screening panel showed no immunitycompletedS
2026-10-27Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
2026-10-27Recombinant zoster vaccine, dose 2 of 2completedS
2026-10-27Influenza vaccine, inactivated trivalent, this season's formulationcompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

No historical medical events are recorded.

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Breathless and tight in the chest late in long nights in the ring, and told his blood pressure is highactiveS
He needs his refereeing work and is afraid of losing his licenseactiveS
Worry about money since losing his savings years ago, and about the cost of medicinesactiveS

Assessment

Most recent measures: Sodium [Moles/volume] in Serum or Plasma 140 on 2026-08-25; Potassium [Moles/volume] in Serum or Plasma 4.4 on 2026-08-25; Urea nitrogen [Mass/volume] in Serum or Plasma 15 on 2026-08-25; Creatinine [Mass/volume] in Serum or Plasma 1.02 on 2026-08-25; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 88 on 2026-08-25; Glucose [Mass/volume] in Serum or Plasma 93 on 2026-08-25; Hemoglobin [Mass/volume] in Blood 14.6 on 2026-05-12; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 2026-05-12; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 2026-05-12; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 2026-05-12; Albumin/Creatinine [Mass Ratio] in Urine 22 on 2026-05-12; Cholesterol [Mass/volume] in Serum or Plasma 138 on 2026-07-28; Cholesterol in HDL [Mass/volume] in Serum or Plasma 47 on 2026-07-28; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 66 on 2026-07-28; Triglyceride [Mass/volume] in Serum or Plasma 124 on 2026-07-28; Lipoprotein a [Moles/volume] in Serum or Plasma 42 on 2026-05-12; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 2026-10-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 2026-10-27; Total score [AUDIT-C] 2 on 2026-05-12; Left ventricular Ejection fraction 62 on 2026-05-26; Interventricular septum Thickness during diastole by US 13 on 2026-05-26; Left ventricular Myocardial mass/Body surface area [Mass/Area] by US 2D 118 on 2026-05-26; Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area 36 on 2026-05-26; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-07-28 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultationresolvedconfirmed R06.09S — Synthetic presenting problem anchored to his documented work as a referee; superseded at the consultation when stress testing showed no ischemia and the symptom was attributed to hypertensive heart disease.
Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to followresolvedconfirmed I10S — Synthetic diagnosis at intake; reclassified as hypertensive heart disease after the echocardiogram at the consultation.
Hypertensive heart disease without heart failure: concentric left ventricular hypertrophy (septum 13 mm, mass index 118 g/m2) with normal ejection fraction, grade 1 diastolic dysfunction, a mildly enlarged left atrium and an exaggerated blood pressure rise on exercise; no features of hypertrophic cardiomyopathyactiveconfirmed I11.9S — Synthetic diagnosis made at the cardiology consultation; not a claim about his real heart.
Coronary atherosclerosis found by coronary calcium scoring (Agatston score 186, about the 80th percentile for his age and sex), without angina and with no inducible ischemia on exercise stress echocardiographyactiveconfirmed I25.10S — Synthetic diagnosis made at the cardiology consultation; not a retrospective diagnosis of the cause of his death, which is disputed.
Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetesactiveconfirmed E78.00S — Synthetic diagnosis at intake.
Volume depletion after refereeing a long card in a heat wave while taking losartan 100 mg with hydrochlorothiazide 25 mg: lightheaded on standing, with an orthostatic fall in blood pressure, a prerenal rise in creatinine to 1.44 mg/dL and potassium 3.3 mmol/L; no fainting, chest pain or arrhythmiaresolvedconfirmed E86.0S — Synthetic acute problem from the thiazide in summer heat; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-12Sodium [Moles/volume] in Serum or Plasma140mmol/L135-146 mmol/LNormalS
2026-05-12Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.3 mmol/LNormalS
2026-05-12Urea nitrogen [Mass/volume] in Serum or Plasma15mg/dL7-25 mg/dLNormalS
2026-05-12Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.7-1.3 mg/dLNormalS
2026-05-12Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M93mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-12Glucose [Mass/volume] in Serum or Plasma96mg/dL65-99 mg/dLNormalS
2026-05-12Hemoglobin [Mass/volume] in Blood14.6g/dL13.5-17.5 g/dLNormalS
2026-05-12Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-55 U/LNormalS
2026-05-12Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-05-12Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4.5 mIU/LNormalS
2026-05-12Albumin/Creatinine [Mass Ratio] in Urine22mg/g{creat}<=29 mg/g{creat}NormalS
2026-05-12Cholesterol [Mass/volume] in Serum or Plasma234mg/dL<=199 mg/dLHighS
2026-05-12Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
2026-05-12Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation160mg/dL<=99 mg/dLHighS
2026-05-12Triglyceride [Mass/volume] in Serum or Plasma150mg/dL<=149 mg/dLHighS
2026-05-12Lipoprotein a [Moles/volume] in Serum or Plasma42nmol/L<=124 nmol/LNormalS
2026-05-12Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-05-12Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S
2026-05-12Total score [AUDIT-C]2{score}S
2026-05-26Sodium [Moles/volume] in Serum or Plasma139mmol/L135-146 mmol/LNormalS
2026-05-26Potassium [Moles/volume] in Serum or Plasma4mmol/L3.5-5.3 mmol/LNormalS
2026-05-26Urea nitrogen [Mass/volume] in Serum or Plasma16mg/dL7-25 mg/dLNormalS
2026-05-26Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.7-1.3 mg/dLNormalS
2026-05-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-26Glucose [Mass/volume] in Serum or Plasma94mg/dL65-99 mg/dLNormalS
2026-05-26Left ventricular Ejection fraction62%52-72%NormalS
2026-05-26Interventricular septum Thickness during diastole by US13mm6-10 mmHighS
2026-05-26Left ventricular Myocardial mass/Body surface area [Mass/Area] by US 2D118g/m249-115 g/m2HighS
2026-05-26Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area36mL/m216-34 mL/m²HighS
2026-06-30Sodium [Moles/volume] in Serum or Plasma138mmol/L135-146 mmol/LNormalS
2026-06-30Potassium [Moles/volume] in Serum or Plasma3.9mmol/L3.5-5.3 mmol/LNormalS
2026-06-30Urea nitrogen [Mass/volume] in Serum or Plasma17mg/dL7-25 mg/dLNormalS
2026-06-30Creatinine [Mass/volume] in Serum or Plasma1.06mg/dL0.7-1.3 mg/dLNormalS
2026-06-30Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M84mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-30Glucose [Mass/volume] in Serum or Plasma95mg/dL65-99 mg/dLNormalS
2026-07-21Sodium [Moles/volume] in Serum or Plasma133mmol/L135-146 mmol/LLowS
2026-07-21Potassium [Moles/volume] in Serum or Plasma3.3mmol/L3.5-5.3 mmol/LLowS
2026-07-21Urea nitrogen [Mass/volume] in Serum or Plasma32mg/dL7-25 mg/dLHighS
2026-07-21Creatinine [Mass/volume] in Serum or Plasma1.44mg/dL0.7-1.3 mg/dLHighS
2026-07-21Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M57mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-07-21Glucose [Mass/volume] in Serum or Plasma104mg/dL65-99 mg/dLHighS
2026-07-28Sodium [Moles/volume] in Serum or Plasma139mmol/L135-146 mmol/LNormalS
2026-07-28Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.3 mmol/LNormalS
2026-07-28Urea nitrogen [Mass/volume] in Serum or Plasma17mg/dL7-25 mg/dLNormalS
2026-07-28Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.7-1.3 mg/dLNormalS
2026-07-28Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M86mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-07-28Glucose [Mass/volume] in Serum or Plasma95mg/dL65-99 mg/dLNormalS
2026-07-28Cholesterol [Mass/volume] in Serum or Plasma138mg/dL<=199 mg/dLNormalS
2026-07-28Cholesterol in HDL [Mass/volume] in Serum or Plasma47mg/dL>=40 mg/dLNormalS
2026-07-28Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation66mg/dL<=99 mg/dLNormalS
2026-07-28Triglyceride [Mass/volume] in Serum or Plasma124mg/dL<=149 mg/dLNormalS
2026-07-28Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-08-25Sodium [Moles/volume] in Serum or Plasma140mmol/L135-146 mmol/LNormalS
2026-08-25Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.3 mmol/LNormalS
2026-08-25Urea nitrogen [Mass/volume] in Serum or Plasma15mg/dL7-25 mg/dLNormalS
2026-08-25Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.7-1.3 mg/dLNormalS
2026-08-25Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M88mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-08-25Glucose [Mass/volume] in Serum or Plasma93mg/dL65-99 mg/dLNormalS
2026-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
2026-10-27Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]3{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-12Body height165cmS
2026-05-12Body weight74.6kgS
2026-05-12Body mass index (BMI) [Ratio]27.4kg/m2S
2026-05-12Systolic blood pressure164mm[Hg]S
2026-05-12Diastolic blood pressure100mm[Hg]S
2026-05-12Heart rate78/minS
2026-05-12Respiratory rate16/minS
2026-05-12Body temperature36.7CelS
2026-05-12Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-05-26Body height165cmS
2026-05-26Body weight74.4kgS
2026-05-26Body mass index (BMI) [Ratio]27.3kg/m2S
2026-05-26Systolic blood pressure148mm[Hg]S
2026-05-26Diastolic blood pressure92mm[Hg]S
2026-05-26Heart rate74/minS
2026-05-26Respiratory rate16/minS
2026-05-26Body temperature36.6CelS
2026-05-26Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-06-30Body height165cmS
2026-06-30Body weight74kgS
2026-06-30Body mass index (BMI) [Ratio]27.2kg/m2S
2026-06-30Systolic blood pressure136mm[Hg]S
2026-06-30Diastolic blood pressure86mm[Hg]S
2026-06-30Heart rate72/minS
2026-06-30Respiratory rate14/minS
2026-06-30Body temperature36.6CelS
2026-06-30Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-25Body height165cmS
2026-08-25Body weight73.4kgS
2026-08-25Body mass index (BMI) [Ratio]27kg/m2S
2026-08-25Systolic blood pressure124mm[Hg]S
2026-08-25Diastolic blood pressure78mm[Hg]S
2026-08-25Heart rate68/minS
2026-08-25Respiratory rate14/minS
2026-08-25Body temperature36.6CelS
2026-08-25Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-27Body height165cmS
2026-10-27Body weight73kgS
2026-10-27Body mass index (BMI) [Ratio]26.8kg/m2S
2026-10-27Systolic blood pressure122mm[Hg]S
2026-10-27Diastolic blood pressure76mm[Hg]S
2026-10-27Heart rate66/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.5CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-07-28Body height165cmS
2026-07-28Body weight73.6kgS
2026-07-28Body mass index (BMI) [Ratio]27kg/m2S
2026-07-28Systolic blood pressure142mm[Hg]S
2026-07-28Diastolic blood pressure88mm[Hg]S
2026-07-28Heart rate72/minS
2026-07-28Respiratory rate14/minS
2026-07-28Body temperature36.6CelS
2026-07-28Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-07-21Body height165cmS
2026-07-21Body weight72.6kgS
2026-07-21Body mass index (BMI) [Ratio]26.7kg/m2S
2026-07-21Systolic blood pressure112mm[Hg]S
2026-07-21Diastolic blood pressure70mm[Hg]S
2026-07-21Heart rate104/minS
2026-07-21Respiratory rate16/minS
2026-07-21Body temperature37.2CelS
2026-07-21Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-05-12Establishing primary care at 50 after a referee's license examination found high blood pressure: exertional breathlessness and chest tightness while refereeing, an ECG showing left ventricular hypertrophy, cardiovascular risk, money worries and mood, and a cardiology consultationfinishedS
2026-05-26Two-week review on the day of the cardiology consultation: the echocardiogram, stress test and calcium score, home blood pressure, a statin, and refereeingfinishedS
2026-06-30Seven-week review: home blood pressure, the first weeks back at full cards, symptoms, and a dose increasefinishedS
2026-08-25Fifteen-week review: blood pressure after the change of medicine, kidney function and potassium, cholesterol on the statin, and the sick visitfinishedS
2026-10-27Twenty-four-week review: blood pressure control, symptoms at work, mood and worry, aspirin, and the plan aheadfinishedS
2026-07-21Same-day sick visit for lightheadedness after refereeing in the heatfinishedS
2026-07-28Periodic adult preventive visit and recheck after the sick visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
High blood pressure: home monitoring with a validated upper-arm cuff, twice a day, with readings sent in weekly; single-pill losartan 50 mg with hydrochlorothiazide 12.5 mg from today, chosen as two first-line drugs for stage 2 hypertension and a low-cost generic; basic metabolic panel in two weeks; target below 130/80 mmHg; less salt (no more than 1,500 to 2,300 mg a day), the DASH pattern, and regular walkingcompletedGL-AHA-HTN-2025, GL-CMID-2026S
Cardiology consultation for exertional breathlessness and chest tightness with left ventricular hypertrophy on the ECG: the cause, the type of hypertrophy, sudden cardiac death risk, coronary risk testing, and whether he can keep refereeingcompletedGL-CHESTPAIN-2021, GL-AHA-HTN-2025, GL-AHA-CCD-2023S
Evaluation at intake: resting ECG, basic metabolic panel, TSH, HbA1c, lipid panel, one-time lipoprotein(a) and urine albumin-to-creatinine ratio; stop and rest, and call the same day for chest discomfort at rest or lasting more than a few minutes, fainting or palpitations; referee only short undercards until the consultationcompletedGL-AHA-HTN-2025, GL-CHESTPAIN-2021, GL-ACC-DYSLIP-2026S
Atorvastatin 40 mg each evening after a coronary calcium score of 186, aiming for LDL below 70 mg/dL and at least a 50% fall, with a lipid panel at eight to twelve weeks; aspirin discussed and not started while blood pressure is uncontrolled, to be revisitedcompletedGL-ACC-DYSLIP-2026, GL-AHA-CCD-2023, GL-ACC-PREV-2019S
Return to work: short undercards until home blood pressure is below 140/90 mmHg, then full cards; drink water between bouts in hot arenas; stop and hand over the bout for chest discomfort, faintness or palpitations; hold the blood pressure tablet on sick days (vomiting, diarrhea, or unable to drink) and call; the venue to keep a defibrillator at ringside with staff trained in CPR; repeat echocardiogram in six to twelve monthscompletedGL-ATHLETE-HTN-2015, GL-AHA-HTN-2025S
Losartan 100 mg with hydrochlorothiazide 25 mg each morning; basic metabolic panel two weeks after the increasecompletedGL-AHA-HTN-2025, GL-CMID-2026S
Volume depletion: oral fluids with salt and potassium-rich foods; hold losartan-hydrochlorothiazide until the recheck in one week; no refereeing until then; emergency care for fainting or chest paincompletedGL-AHA-HTN-2025S
Change to losartan 100 mg and amlodipine 5 mg each morning, without the thiazide, because of heavy sweating in hot arenas; basic metabolic panel in four weeks; written sick-day rules on a card for his walletcompletedGL-AHA-HTN-2025, GL-CMID-2026S
Money worries and mood: PHQ-9 and GAD-7 at intake and at six months; generic once-daily medicines at the lowest cost; a social needs screen; brief support and problem-solving at each visitcompletedGL-USPSTF-DEP-2023, GL-USPSTF-ANX-2023S

Goals

GoalTargetStatusOutcomeProvenance
Find the cause of the exertional breathlessness and chest tightness2026-05-26completedNo inducible ischemia; symptoms from hypertensive heart disease with an exaggerated blood pressure responseS
Blood pressure below 130/80 mmHg at home and in the clinic2026-08-25completed164/100 at intake to 124/78 in the clinic, home average 122/76 mmHgS
LDL below 70 mg/dL and at least 50% lower than at intake2026-07-28completedLDL 160 to 66 mg/dL (59% lower) on atorvastatin 40 mgS
Keep refereeing full cards safely, without symptoms2027-05-12activeBack to full cards after the blood pressure fell; no symptoms since; a week off after the sick visitS
Regression of left ventricular hypertrophy on a repeat echocardiogram2027-05-26activeRepeat echocardiogram due six to twelve months after the firstS

Functional Status

Mental Status